Vitrolife AB (publ) (VTRLY)
OTCMKTS · Delayed Price · Currency is USD
15.87
+0.97 (6.51%)
Aug 28, 2025, 2:39 PM EDT
Vitrolife AB Market Cap
Vitrolife AB has a market cap or net worth of $1.90 billion as of August 28, 2025. Its market cap has decreased by -32.92% in one year.
Market Cap
1.90B
Enterprise Value
2.01B
Revenue
372.37M
Ranking
n/a
PE Ratio
39.72
Stock Price
$15.87
Market Cap Chart
Since June 27, 2001, Vitrolife AB's market cap has increased from 47.59M to 1.90B, an increase of 3,893.97%. That is a compound annual growth rate of 16.47%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 27, 2025 | 1.90B | -27.89% |
| Dec 30, 2024 | 2.64B | 0.83% |
| Dec 29, 2023 | 2.61B | 8.07% |
| Dec 30, 2022 | 2.42B | -71.15% |
| Dec 30, 2021 | 8.38B | 193.22% |
| Dec 30, 2020 | 2.86B | 24.29% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 972.93M |
| Veradigm | 823.67M |
| Tian'an Technology Group | 682.77M |
| Glass House Brands | 636.43M |
| Elite Pharmaceuticals | 587.83M |
| CytoDyn | 388.66M |
| Northwest Biotherapeutics | 357.21M |
| American Oncology Network | 357.05M |